Literature DB >> 22752408

Maspin: molecular mechanisms and therapeutic implications.

Thomas M Bodenstine1, Richard E B Seftor, Zhila Khalkhali-Ellis, Elisabeth A Seftor, Philip A Pemberton, Mary J C Hendrix.   

Abstract

Maspin, a non-inhibitory member of the serine protease inhibitor superfamily, has been characterized as a tumor suppressor gene in multiple cancer types. Among the established anti-tumor effects of Maspin are the inhibition of cancer cell invasion, attachment to extracellular matrices, increased sensitivity to apoptosis, and inhibition of angiogenesis. However, while significant experimental data support the role of Maspin as a tumor suppressor, clinical data regarding the prognostic implications of Maspin expression have led to conflicting results. This highlights the need for a better understanding of the context dependencies of Maspin in normal biology and how these are perturbed in the context of cancer. In this review, we outline the regulation and roles of Maspin in normal and developmental biology while discussing novel evidence and emerging theories related to its functions in cancer. We provide insight into the immense therapeutic potential of Maspin and the challenges related to its successful clinical translation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752408     DOI: 10.1007/s10555-012-9361-0

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  36 in total

1.  Proteolytic activation transforms heparin cofactor II into a host defense molecule.

Authors:  Martina Kalle; Praveen Papareddy; Gopinath Kasetty; Douglas M Tollefsen; Martin Malmsten; Matthias Mörgelin; Artur Schmidtchen
Journal:  J Immunol       Date:  2013-05-08       Impact factor: 5.422

2.  Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.

Authors:  Jung Ho Kim; Nam-Yun Cho; Jeong Mo Bae; Kyung-Ju Kim; Ye-Young Rhee; Hye Seung Lee; Gyeong Hoon Kang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 3.  Temporal bone carcinoma: a first glance beyond the conventional clinical and pathological prognostic factors.

Authors:  Gino Marioni; Alessandro Martini; Niccolò Favaretto; Sebastiano Franchella; Rocco Cappellesso; Filippo Marino; Stella Blandamura; Antonio Mazzoni; Elisabetta Zanoletti
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-30       Impact factor: 2.503

4.  Elderly patients at higher risk of laryngeal carcinoma recurrence could be identified by a panel of two biomarkers (nm23-H1 and CD105) and pN+ status.

Authors:  Andrea Lovato; Gino Marioni; Enzo Manzato; Claudia Staffieri; Luciano Giacomelli; Giovanni Ralli; Alberto Staffieri; Stella Blandamura
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-04       Impact factor: 2.503

5.  Cancer Cell-Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma.

Authors:  Chenxi Tian; Daniel Öhlund; Steffen Rickelt; Tommy Lidström; Ying Huang; Liangliang Hao; Renee T Zhao; Oskar Franklin; Sangeeta N Bhatia; David A Tuveson; Richard O Hynes
Journal:  Cancer Res       Date:  2020-02-06       Impact factor: 12.701

6.  Expression and clinical significance of microRNA-21, maspin and vascular endothelial growth factor-C in bladder cancer.

Authors:  Hui-Hui Zhang; Fan Qi; You-Han Cao; Xiong-Bing Zu; Min-Feng Chen
Journal:  Oncol Lett       Date:  2015-07-28       Impact factor: 2.967

Review 7.  Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors.

Authors:  Ulrich H Weidle; Fabian Birzele; Georg Tiefenthaler
Journal:  Cancer Genomics Proteomics       Date:  2018 Jul-Aug       Impact factor: 4.069

Review 8.  Tumor suppressor maspin as a modulator of host immune response to cancer.

Authors:  Sijana H Dzinic; Maria M Bernardo; Daniel S M Oliveira; Marian Wahba; Wael Sakr; Shijie Sheng
Journal:  Bosn J Basic Med Sci       Date:  2015-10-25       Impact factor: 3.363

9.  Tumor-suppressive maspin functions as a reactive oxygen species scavenger: importance of cysteine residues.

Authors:  Nitin Mahajan; Heidi Y Shi; Thomas J Lukas; Ming Zhang
Journal:  J Biol Chem       Date:  2013-03-07       Impact factor: 5.157

10.  Cytoplasmic Maspin Expression Correlates with Poor Prognosis of Patients with Adenocarcinoma of the Uterine Cervix.

Authors:  Kanae Nosaka; Yasushi Horie; Tatsushi Shiomi; Hiroaki Itamochi; Tetsuro Oishi; Muneaki Shimada; Shinya Sato; Tomohiko Sakabe; Tasuku Harada; Yoshihisa Umekita
Journal:  Yonago Acta Med       Date:  2015-12-18       Impact factor: 1.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.